RecruitingNot ApplicableNCT07736963

Discontinuation Recommendations for GLP-1 Receptor Agonists Prior to Colonoscopy

Discontinuation Recommendations for GLP-1 Receptor Agonists Prior to Colonoscopy: A Randomized Controlled Trial in Taiwan.

Sponsor

Fu Jen Catholic University Hospital

Enrollment

240 participants

Start Date

Jun 1, 2026

Study Type

INTERVENTIONAL

Conditions

GLP - 1

Summary

This study aims to evaluate the impact of different discontinuation intervals of GLP-1 receptor agonists prior to colonoscopy on bowel preparation quality and the need for repeat colonoscopy, in order to establish appropriate discontinuation recommendations.

Eligibility

Min Age: 18 YearsMax Age: 90 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a behavioral approach called GLP-1 not stop for 1 week and a behavioral approach called GLP-1 stop for 1 week for people with glp - 1. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 90 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.